Nutanix improves financials with robust strategies against VMware, offering cost efficiencies. Strong margins ahead, but high ...
Nutanix study reveals that GenAI is changing organizations’ priorities, with security and privacy being a primary concern ...
In the closing of the recent trading day, Nutanix (NTNX) stood at $70.28, denoting a -1.83% change from the preceding trading day.
Nutanix offers healthcare organizations a streamlined, scalable path to adopting GenAI technologies with Nutanix Enterprise ...
Analyst evaluates Nutanix's growth prospects, cost pressures, and stock valuation in light of earnings growth and industry ...
ITWeb on MSN4d
Rapid GenAI application adoption drives new era of application, infrastructure modernisationA Nutanix study reveals GenAI is changing organisations' priorities, with security and privacy being a primary concern.
We’re spending more time analyzing the back end of AI in terms of the models being built and the IT services being used to run it, rather than the use cases itself.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback